A
Anhui Sunhere Pharmaceutical Excipients Co Ltd
SZSE:300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
SZSE:300452
Price:
15.62
CNY
-0.57%
Market Closed
Market Cap:
¥3.7B
Relative Value
The Relative Value of one Anhui Sunhere Pharmaceutical Excipients Co Ltd stock under the Base Case scenario is 12.74 CNY. Compared to the current market price of 15.62 CNY, Anhui Sunhere Pharmaceutical Excipients Co Ltd is Overvalued by 18%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
12.74
CNY
Overvaluation 18%
A
Multiples Across Competitors
Competitors Multiples
Anhui Sunhere Pharmaceutical Excipients Co Ltd Competitors
Anhui Sunhere Pharmaceutical Excipients Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
A
|
Anhui Sunhere Pharmaceutical Excipients Co Ltd
SZSE:300452
|
3.6B CNY | 3.9 | 28 | 22.5 | 22.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
957.3B USD | 14.8 | 46.6 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
589.5B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.4B CHF | 4.8 | 31 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.7B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
243.9B CHF | 5.5 | 22.3 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.1B USD | 4.6 | 16.5 | 10.3 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
